liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Mycobacterial respiratory chain enzymes and growth are inhibited by decylubiquinone
Stockholm Univ, Sweden.
Stockholm Univ, Sweden.
Stockholm Univ, Sweden.
Linköping University, Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection. Linköping University, Faculty of Medicine and Health Sciences.
Show others and affiliations
2025 (English)In: Communications Biology, E-ISSN 2399-3642, Vol. 9, no 1, article id 43Article in journal (Refereed) Published
Abstract [en]

Aerobic organisms obtain energy by linking electron transfer from NADH to O2, through the respiratory chain, to transmembrane proton translocation. In mycobacteria the respiratory chain is branched; the membrane-bound electron carrier menaquinol (MQH2) donates electrons either to the O2-reducing cytochrome bd or a supercomplex that is composed of a complex (C) III2 dimer flanked by two CIVs. Here, we measured the dimethyl-naphthoquinone (DMNQH2, a menaquinol analogue) oxidation:O2 reduction activities of the CIII2CIV2 supercomplex and cytochrome bd in the presence of an analogue (decylubiquinone, DCQ) of the mammalian electron carrier, ubiquinol. The data show that DCQH2 inhibits both the CIII2CIV2 and cytochrome bd activities, suggesting that DCQ/DCQH2 interferes with both branches of the respiratory chain. Cryo-EM data of the M. smegmatis supercomplex shows that oxidized DCQ binds in the electron donor site (Qo) of CIII2. Accordingly, growth of M. smegmatis cells was impaired in the presence of DCQ. Remarkably, DCQ also impairs intracellular growth of virulent M. tuberculosis cells in human primary macrophages suggesting that the compound could potentially be used as an adjuvant during tuberculosis disease treatment.

Place, publisher, year, edition, pages
NATURE PORTFOLIO , 2025. Vol. 9, no 1, article id 43
National Category
Structural Biology
Identifiers
URN: urn:nbn:se:liu:diva-220834DOI: 10.1038/s42003-025-09309-9ISI: 001657997900001PubMedID: 41372535Scopus ID: 2-s2.0-105027058918OAI: oai:DiVA.org:liu-220834DiVA, id: diva2:2033542
Note

Funding Agencies|Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation) [2019.0043, 2023.0201]; Foundation to Prevent Antimicrobial Resistance

Available from: 2026-01-29 Created: 2026-01-29 Last updated: 2026-03-29

Open Access in DiVA

fulltext(5592 kB)63 downloads
File information
File name FULLTEXT01.pdfFile size 5592 kBChecksum SHA-512
c70652de84698f6c9a8027a6b1a033000a8ade880bb89e72fa07cddb4c345270375fe2bc14ffbef4ab043c9fcc32f9fca3202f9f5ddac33881c53d7bfdaab09a
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Kalsum, Sadaf
By organisation
Division of Inflammation and InfectionFaculty of Medicine and Health Sciences
In the same journal
Communications Biology
Structural Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 63 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 41 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf